BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/25/2025 9:07:44 AM | Browse: 246 | Download: 716
 |
Received |
|
2024-07-02 03:31 |
|
Peer-Review Started |
|
2024-07-02 03:31 |
|
First Decision by Editorial Office Director |
|
2024-08-10 03:05 |
|
Return for Revision |
|
2024-08-10 11:36 |
|
Revised |
|
2024-08-31 01:57 |
|
Publication Fee Transferred |
|
2025-04-07 13:27 |
|
Second Decision by Editor |
|
2024-09-14 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-14 09:44 |
|
Articles in Press |
|
2024-09-14 09:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-04-16 11:57 |
|
Publish the Manuscript Online |
|
2025-04-25 08:23 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Case Report |
| Article Title |
Dual therapy with nucleos(t)ide analogues in the prevention of hepatitis B virus recurrence after liver transplantation: Two case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nicolás Ortiz-López, Maximiliano Acevedo, Tamara Vergara, Juan Pablo Roblero, Álvaro Urzúa, Máximo Cattaneo and Jaime Poniachik |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jaime Poniachik, MD, Chief Physician, Doctor, Doctor, Sección de Gastroenterología, Hospital Clínico Universidad de Chile, Carlos Lorca Tobar 999, Independencia, Santiago 8380453, Región Metropolitana, Chile. jponiachik@hcuch.cl |
| Key Words |
Antiviral drug; Liver transplant; Hepatitis B virus; Viral recurrence; Nucleoside analog; Case report |
| Core Tip |
This manuscript explores post-liver transplant strategies for hepatitis B virus (HBV). Two cases showed the success of dual nucleoside/nucleotide analog (NA) therapy (entecavir and tenofovir alafenamide) without hepatitis B immunoglobulin (HBIG) in prevention of HBV recurrence. These cases emphasize the efficacy of dual NA therapy as a viable alternative in managing post-transplant HBV infection, especially when HBIG is unavailable. This challenges the standard protocol and proposes reconsidering post-transplant management when specific treatments are limited. |
| Publish Date |
2025-04-25 08:23 |
| Citation |
Ortiz-López N, Acevedo M, Vergara T, Roblero JP, Urzúa Á, Cattaneo M, Poniachik J. Dual therapy with nucleos(t)ide analogues in the prevention of hepatitis B virus recurrence after liver transplantation: Two case reports. World J Hepatol 2025; 17(4): 98660 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i4/98660.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i4.98660 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
